French drug maker Sanofi reported a slight decline in third-quarter profit, dented by restructuring costs, but confirmed its earnings guidance for 2014.
from WSJ.com: US Business http://ift.tt/1pTrgLp
via IFTTT
from WSJ.com: US Business http://ift.tt/1pTrgLp
via IFTTT
No comments:
Post a Comment